Edition:
India

Strides Shasun Ltd (STSA.NS)

STSA.NS on National Stock Exchange of India

394.80INR
3:57pm IST
Change (% chg)

Rs1.85 (+0.47%)
Prev Close
Rs392.95
Open
Rs395.05
Day's High
Rs402.95
Day's Low
Rs383.60
Volume
6,779,375
Avg. Vol
2,666,288
52-wk High
Rs1,102.20
52-wk Low
Rs333.30

Select another date:

Tue, Jun 12 2018

BUZZ-India's Strides Shasun rises on US FDA nod for flu treatment

** Shares of Strides Shasun Ltd climb as much as 5.5 pct to 369 rupees

BUZZ-India's Strides Shasun extends losses on disappointing Q4

** Shares in pharmaceutical company Strides Shasun Ltd slip for a second session; fall as much as 8.7 pct to 353.40 rupees, lowest since April 2014

BUZZ-India's Strides Shasun plunges, loses most in over 10 years

** Shares of Strides Shasun Ltd dives nearly 25 pct to 378.20 rupees, their lowest since early April 2014

BRIEF-India's Strides Shasun March-Qtr Consol Profit Rises Five-Fold

* MARCH QUARTER CONSOL NET PROFIT 5.68 BILLION RUPEES VERSUS PROFIT OF 1.12 BILLION RUPEES LAST YEAR

BUZZ-India's Strides Shasun rises after merger deal with Apotex

** Shares in Strides Shasun Ltd rise as much as 2.6 pct to 566.60 rupees

BRIEF-India's Strides Shasun Gets U.S. FDA Nod For Cinacalcet Hydrochloride Tablets

* STRIDES SHASUN RECEIVES USFDA APPROVAL FOR CINACALCET HYDROCHLORIDE TABLETS

BRIEF-Strides Shasun To Divest Holding In Remaining API Asset At Ambernath

* SAYS TO DIVEST ITS HOLDING IN REMAINING API ASSET AT AMBERNATH TO SOLARA ACTIVE PHARMA SCIENCES LIMITED

BRIEF-Strides Shasun Says NCLT Approves Co's Scheme Of Arrangement With Sequent Scientific And Solara Active Pharma Sciences

* SAYS NCLT APPROVED COMPOSITE SCHEME OF ARRANGEMENT BETWEEN CO, SEQUENT SCIENTIFIC AND SOLARA ACTIVE PHARMA SCIENCES Source text - http://bit.ly/2HLmsbG Further company coverage:

BRIEF-India's Strides Shasun Gets U.S. FDA Nod For Cyproheptadine Hydrochloride Tablets

* GETS USFDA APPROVAL FOR CYPROHEPTADINE HYDROCHLORIDE TABLETS

BRIEF-Strides Shasun Gets U.S. FDA Approval For Ibuprofen Softgel OTC Capsules

* SAYS CO GETS U.S. FDA APPROVAL FOR IBUPROFEN SOFTGEL OTC CAPSULES Source text - https://bit.ly/2Gu3qoC Further company coverage:

Select another date: